Aquestive Therapeutics (AQST) EPS (Weighted Average and Diluted) (2020 - 2026)
Aquestive Therapeutics (AQST) recorded quarterly EPS (Weighted Average and Diluted) of -$0.07 in Q1 2026, up 74.07% quarter-over-quarter from -$0.27 in Q4 2025, and up 70.83% on a YoY basis from -$0.04 in Q1 2025.
Aquestive Therapeutics (AQST) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Aquestive Therapeutics' EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$0.07 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 70.83% year-over-year to -$0.07; the TTM figure through Mar 2026 stood at -$0.62 (down 5.08% YoY), while the FY2025 annual figure was -$0.78, down 52.94% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.07 for Q1 2026 at Aquestive Therapeutics, up from -$0.27 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.11 in Q1 2023 to a low of -$0.36 in Q2 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.16 across 5 years, with a median of -$0.14 in 2025.
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) soared 134.38% in 2023, then slumped 366.67% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.22 in 2022, then jumped by 40.91% to -$0.13 in 2023, then sank by 46.15% to -$0.19 in 2024, then slumped by 42.11% to -$0.27 in 2025, then jumped by 74.07% to -$0.07 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.07 (Q1 2026), -$0.27 (Q4 2025), and -$0.14 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.19 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.13 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | 0.11 |
| Dec 31, 2022 | -0.22 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.36 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.73 |
| Sep 30, 2021 | -0.37 |
| Jun 30, 2021 | -0.33 |